Keep up to date with news from Gamma Gurus

IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions | IBA Group (iba-worldwide.com)

Gamma Gurus proudly announces an agreement with IBA to market their Radio Pharma Solutions portfolio in Australia & New Zealand. This strengthens our radiopharmaceutical production solutions support to the NM&MMI community including cyclotron produced isotopes for diagnosis and therapy. With over 450 cyclotrons between 3MeV and 235MeV beam energy installed world-wide, including over 100 Cyclone KIUBE cyclotrons, we look forward to extending IBA’s RPS installed base in Australasia.

Recently announced at ASTRO 2023, 12 months after the merger was first announced, CIVCO RT and Qfix have rebranded the combined business as CQ Medical. CQ Medical are the new global leader in patient radiotherapy positioning and healthcare innovations that advance human care. From researchers and scientists to designers and developers, CQ Medical is at the forefront of cutting-edge, patient-centric medical technology designed to deliver the best possible outcomes. Read more about how IQ + EQ = CQ here.

After 25 years, IBA is still able to offer upgrades on their very first Proton Therapy system allowing Mass General Cancer Center to continue treating patients with the most up-to-date technology.  The ability to upgrade systems in the field is one of IBA's many unique differentiators.   IBA plans total system restoration on its first-ever proton therapy installation | IBA Group (iba-worldwide.com)

We are delighted that Cancer Care Associates have selected C-RAD as their SGRT vendor for their ongoing expansion! https://c-rad.com/press-releases/c-rad-has-been-selected-by-australian-cancer-care-associates-cca-for-their-cancer-clinics-across-australia/